Inhibition of direct and indirect TLR-mediated activation of human NK cells by low molecular weight dextran sulfate

Molecular Immunology

Volumn 47, Issue 14, 2010, Pages 2349-2358

  Millard, Anne Laure ^a   Spirig, Rolf ^b   Mueller, Nicolas J ^a   Seebach, Jörg D ^c   Rieben, Robert ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c University Hospital and Medical Faculty ^*  (Switzerland)

Author keywords

Dendritic cells; Immunomodulation; NK cells; Toll like receptor; Transplantation

Indexed keywords

CD56 ANTIGEN; CD69 ANTIGEN; DEXTRAN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST;

ARTICLE; CELL ACTIVATION; DEGRANULATION; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

CELL DEGRANULATION; CELL SURVIVAL; COMPLEMENT INACTIVATING AGENTS; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; DEXTRAN SULFATE; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MOLECULAR WEIGHT; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 77955414627     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.05.284     Document Type: Article

References (59)

1. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., Klimpel G.R., Godowski P., Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999, 285:736-739.
2. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 2004, 294:15-22.
3. Austin T.M., Bennett M., Kumar V., Schatzle J.D. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice. J. Immunol. 2000, 165:5048-5053.
4. Bach F.H., Robson S.C., Winkler H., Ferran C., Stuhlmeier K.M., Wrighton C.J., Hancock W.W. Barriers to xenotransplantation. Nat. Med. 1995, 1:869-873.
5. Banz Y., Hess O.M., Robson S.C., Mettler D., Meier P., Haeberli A., Csizmadia E., Korchagina E.Y., Bovin N.V., Rieben R. Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury. Eur. Heart J. 2005, 26:2334-2343.
6. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L.G., Ruiz A., Cervantes R., Torres A.P., Cabrera N., Gonzalez A., Maldonado C., Isibasi A. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol. Biochem. Parasitol. 2003, 130:65-74.
7. Chalifour A., Jeannin P., Gauchat J.F., Blaecke A., Malissard M., N'Guyen T., Thieblemont N., Delneste Y. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 2004, 104:1778-1783.
8. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., Rock K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 2007, 13:851-856.
9. Della C.M., Sivori S., Castriconi R., Marcenaro E., Moretta A. Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol. 2005, 13:128-136.
10. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., Bougras G., Muller W.A., Moretta L., Munz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16606-16611.
11. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002, 195:343-351.
12. Forbes J.T., Bretthauer R.K., Oeltmann T.N. Mannose 6-, fructose 1-, and fructose 6-phosphates inhibit human natural cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:5797-5801.
13. Forte P., Lilienfeld B.G., Baumann B.C., Seebach J.D. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J. Immunol. 2005, 175:5463-5470.
14. Gajanayake T., Sawitzki B., Matozan K., Korchagina E.Y., Lehmann M., Volk H.D., Rieben R. Dextran sulfate facilitates anti-CD4 mAb-induced long-term rat cardiac allograft survival after prolonged cold ischemia. Am. J. Transplant. 2008, 8:1151-1162.
15. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002, 195:327-333.
16. Gorski K.S., Waller E.L., Bjornton-Severson J., Hanten J.A., Riter C.L., Kieper W.C., Gorden K.B., Miller J.S., Vasilakos J.P., Tomai M.A., Alkan S.S. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int. Immunol. 2006, 18:1115-1126.
17. Hart O.M., Athie-Morales V., O'Connor G.M., Gardiner C.M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J. Immunol. 2005, 175:1636-1642.
18. Holbrook N.J., Cox W.I., Horner H.C. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res. 1983, 43:4019-4025.
19. Ihrcke N.S., Platt J.L. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J. Cell Physiol. 1996, 168:625-637.
20. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., Lee H., Lee J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130:1071-1082.
21. Johnson G.B., Brunn G.J., Kodaira Y., Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 2002, 168:5233-5239.
22. Krishnaraj R., Bhooma T. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL2-induced interferon gamma secretion. Immunol. Lett. 1996, 50:59-63.
23. Lakshmikanth T., Burke S., Ali T.H., Kimpfler S., Ursini F., Ruggeri L., Capanni M., Umansky V., Paschen A., Sucker A., Pende D., Groh V., Biassoni R., Hoglund P., Kato M., Shibuya K., Schadendorf D., Anichini A., Ferrone S., Velardi A., Karre K., Shibuya A., Carbone E., Colucci F. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J. Clin. Invest. 2009, 119:1251-1263.
24. Laumonier T., Mohacsi P.J., Matozan K.M., Banz Y., Haeberli A., Korchagina E.Y., Bovin N.V., Vanhove B., Rieben R. Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation. Am. J. Transplant. 2004, 4:181-187.
25. Laumonier T., Walpen A.J., Maurus C.F., Mohacsi P.J., Matozan K.M., Korchagina E.Y., Bovin N.V., Vanhove B., Seebach J.D., Rieben R. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells. Transplantation 2003, 76:838-843.
26. Leemans J.C., Stokman G., Claessen N., Rouschop K.M., Teske G.J., Kirschning C.J., Akira S., van der Poll T., Weening J.J., Florquin S. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 2005, 115:2894-2903.
27. Li S., Yan Y., Lin Y., Bullens D.M., Rutgeerts O., Goebels J., Segers C., Boon L., Kasran A., De V.R., Dewolf-Peeters C., Waer M., Billiau A.D. Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. Blood 2007, 110:3926-3935.
28. Lilienfeld B.G., Garcia-Borges C., Crew M.D., Seebach J.D. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D. J. Immunol. 2006, 177:2146-2152.
29. Luke H.J., Prehm P. Synthesis and shedding of hyaluronan from plasma membranes of human fibroblasts and metastatic and non-metastatic melanoma cells. Biochem. J. 1999, 343(Pt 1):71-75.
30. Maier S., Tertilt C., Chambron N., Gerauer K., Huser N., Heidecke C.D., Pfeffer K. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat. Med. 2001, 7:557-562.
31. Mentzer S.J., Guyre P.M., Burakoff S.J., Faller D.V. Spontaneous aggregation as a mechanism for human monocyte purification. Cell Immunol. 1986, 101:312-319.
32. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001, 19:197-223.
33. Mortier E., Woo T., Advincula R., Gozalo S., Ma A. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 2008, 205:1213-1225.
34. Muzio M., Bosisio D., Polentarutti N., D'amico G., Stoppacciaro A., Mancinelli R., van't Veer C., Penton-Rol G., Ruco L.P., Allavena P., Mantovani A. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 2000, 164:5998-6004.
35. Nilsen N.J., Deininger S., Nonstad U., Skjeldal F., Husebye H., Rodionov D., von A.S., Hartung T., Lien E., Bakke O., Espevik T. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J. Leukoc. Biol. 2008, 84:280-291.
36. O'Connor G.M., Hart O.M., Gardiner C.M. Putting the natural killer cell in its place. Immunology 2006, 117:1-10.
37. Obregon C., Rothen-Rutishauser B., Gitahi S.K., Gehr P., Nicod L.P. Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. Am. J. Pathol. 2006, 169:2127-2136.
38. Pangburn M.K., Atkinson M.A., Meri S. Localization of the heparin-binding site on complement factor H. J. Biol. Chem. 1991, 266:16847-16853.
39. Piccioli D., Sbrana S., Melandri E., Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 2002, 195:335-341.
40. Pisegna S., Pirozzi G., Piccoli M., Frati L., Santoni A., Palmieri G. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 2004, 104:4157-4164.
41. Platt J.L., Dalmasso A.P., Lindman B.J., Ihrcke N.S., Bach F.H. The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur. J. Immunol. 1991, 21:2887-2890.
42. Platt J.L., Vercellotti G.M., Lindman B.J., Oegema T.R., Bach F.H., Dalmasso A.P. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J. Exp. Med. 1990, 171:1363-1368.
43. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003, 3:781-790.
44. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179:1109-1118.
45. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 1999, 274:17406-17409.
46. Sivori S., Falco M., Della C.M., Carlomagno S., Vitale M., Moretta L., Moretta A. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10116-10121.
47. Spirig R., Gajanayake T., Korsgren O., Nilsson B., Rieben R. Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation. Mol. Immunol. 2008, 45:4084-4094.
48. Spirig R., van K.C., Obregon C., Nicod L., Daha M., Rieben R. The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cells. J. Immunol. 2008, 181:878-890.
49. Stutman O., Dien P., Wisun R.E., Lattime E.C. Natural cytotoxic cells against solid tumors in mice: blocking of cytotoxicity by d-mannose. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:2895-2898.
50. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 2004, 279:17079-17084.
51. Taylor K.R., Yamasaki K., Radek K.A., Di N.A., Goodarzi H., Golenbock D., Beutler B., Gallo R.L. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 2007, 282:18265-18275.
52. Taylor P.A., Ehrhardt M.J., Lees C.J., Panoskaltsis-Mortari A., Krieg A.M., Sharpe A.H., Murphy W.J., Serody J.S., Hemmi H., Akira S., Levy R.B., Blazar B.R. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood 2008, 112:3508-3516.
53. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., Simon J.C. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 2002, 195:99-111.
54. Tu Z., Bozorgzadeh A., Pierce R.H., Kurtis J., Crispe I.N., Orloff M.S. TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 2008, 205:233-244.
55. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 1998, 187:2065-2072.
56. Vitale M., Della C.M., Carlomagno S., Pende D., Arico M., Moretta L., Moretta A. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005, 106:566-571.
57. Wu H., Chen G., Wyburn K.R., Yin J., Bertolino P., Eris J.M., Alexander S.I., Sharland A.F., Chadban S.J. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 2007, 117:2847-2859.
58. Wuillemin W.A., te Velthuis H., Lubbers Y.T., de Ruig C.P., Eldering E., Hack C.E. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. J. Immunol. 1997, 159:1953-1960.
59. Xu X.C., Goodman J., Sasaki H., Lowell J., Mohanakumar T. Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse. Am. J. Transplant. 2002, 2:314-322.